Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03794089 · ClinicalTrials.gov registry record · NA
Reducing Anxiety and Stress in Primary Care Patients
A NA study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 35
- Enrollment target
NCT03794089: Completed NA study, sponsored by VA Office of Research and Development.
NCT03794089 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 35 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03794089, a NA study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
Study Summary
Anxiety is common among primary care patients, but is undertreated. The purpose of this study is to evaluate whether a brief anxiety treatment designed for VA primary care is more effective at reducing anxiety symptoms in Veterans compared to usual care. The investigators will also examine whether Veterans like the brief treatment and whether the treatment can be feasibly delivered in primary care. Forty-eight adult Veteran primary care patients from the Syracuse VAMC who are experiencing anxiety symptoms will be recruited and randomly assigned to receive the brief anxiety treatment or usual care. The brief treatment consists of up to six 30-minute sessions with a cognitive-behavioral skills focus. The investigators will compare anxiety symptom severity between the two groups at baseline and at post-assessment 16 weeks later.
Interventions
- BEHAVIORAL Brief anxiety intervention
- BEHAVIORAL Usual PC-MHI care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2019-04-01 |
| Est. Completion | 2021-12-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03794089
The ClinicalTrials.gov registry entry for NCT03794089 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Brief anxiety intervention is the first listed.
NCT03794089 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03794089 about?
NCT03794089 is a clinical study titled "Reducing Anxiety and Stress in Primary Care Patients". Anxiety is common among primary care patients, but is undertreated. The purpose of this study is to evaluate whether a brief anxiety treatment designed for VA primary care is more effective at reducing anxiety symptoms in Veterans compared to usual care. The investigators will also examine whether V...
What is the current status of trial NCT03794089?
This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2019-04-01. Estimated completion is 2021-12-30.
What interventions are being tested in trial NCT03794089?
The interventions under investigation include: Brief anxiety intervention (BEHAVIORAL), Usual PC-MHI care (BEHAVIORAL).
Who is sponsoring clinical trial NCT03794089?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.